Predicting factors of echocardiographic super-response to cardiac resynchronization therapy

J Clin Ultrasound. 2023 Mar;51(3):388-393. doi: 10.1002/jcu.23380. Epub 2022 Nov 11.

Abstract

Purpose: To investigate the clinical and echocardiographic predictors of echocardiographic super-response to cardiac resynchronization therapy (CRT) in heart failure patients.

Methods: We retrospectively collected data from 97 patients, who underwent CRT and were followed up (median time = 20.33 months). All had left ventricular ejection fraction (LVEF) ≤35%, New-York-Heart-Association class 3 or 4, and Q wave, R wave and S wave (QRS) duration >120 ms. Time-to-peak systolic velocity was measured for individual LV segments by tissue Doppler imaging prior to CRT. Two-dimensional echocardiography was carried out before and at follow-up, and ≥12.5% increase in LVEF was defined as super-response.

Results: From the 97 patients, 23 (23.7%) were super-responders. Super-responders were more frequently female (52.2% vs. 24.3%, respectively; p value = 0.012). Among super-responders, the mean of LV end-diastolic and end-systolic volumes were significantly lower. According to dyssynchrony indices, time delay between anteroseptal and posterior wall and SD of all LV segments timing showed significantly higher values in super-responders. By multivariate analysis, LV end-systolic volume and anteroseptal-to-posterior wall delay remained independently associated with echocardiographic super-response to CRT.

Conclusion: About one-fourth of our patients with CRT were super-responder in that they had ≥12.5% increase in LVEF by echocardiography. Among all the clinical and echocardiographic measures, only lower LV end-systolic volume and higher anteroseptal-to-posterior wall delay predicted super-response.

Keywords: cardiac resynchronization therapy; echocardiography; response; tissue Doppler imaging.

MeSH terms

  • Cardiac Resynchronization Therapy* / methods
  • Echocardiography / methods
  • Female
  • Heart Failure* / diagnostic imaging
  • Heart Failure* / therapy
  • Humans
  • Retrospective Studies
  • Stroke Volume / physiology
  • Treatment Outcome
  • Ventricular Dysfunction, Left*
  • Ventricular Function, Left